Skip to main content
☰
moat
keep
Markets
Screener
Research
Editorials
Pricing
About
⌘K
Sign in
Start free
NERVGEN PHARMA CORP. (NGEN) | Moatkeep
Companies
/
Nasdaq
/
NGEN
NERVGEN PHARMA CORP.
NGEN · Nasdaq
$1.62
+1.25%
Close, 2026-07-31
Close, 2026-07-31 · source: Databento · USD · figures not investment advice
+ Alert
★ Watchlist
Overview
Valuation
Financials
Reports
Editorials & Research
Business
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
MAX
⤢ Expand
Price
▾
Log
Volume
Data under review
Price
State of incorporation
A1
Fiscal year end
Dec 31
Financials · five years
Investor
Revenue
•••••
•••••
•••••
Gross profit
•••••
•••••
•••••
Operating income
•••••
•••••
•••••
Net income
•••••
•••••
•••••
Free cash flow
•••••
•••••
•••••
Investor
Read the full financial statements
Free accounts read five years of annual financials.
Create a free account
Source: SEC EDGAR (XBRL) · figures in CAD millions
View full financials →
⏳
More profile depth coming soon — risk factors, MD&A summary, and peer comparisons.